Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Call for greater access to animal medicine
drugs
"One of the major reasons attributable for the lack of availability and accessibility of quality veterinary medicines and vaccines is the lack of an appropriate, robust and functioning regulatory system."

Conference highlights the need for government collaboration 

The global animal medicines association, HealthforAnimals, has appealed for greater worldwide access to veterinary medicines. The organisation, speaking at the fifth Global Animal Health Conference in Delhi, urged representatives from 24 countries to improve regional cooperation in order to improve the availability of animal medicines.
 
The conference, supported by the Bill and Melinda Gates Foundation, emphasised the socio-economic benefits of providing farmers with access to quality animal health products. Through enabling access, livestock can be immunised and treated for disease, ensuring the livelihood of communities and protecting against transferable diseases.
 
Opening the conference, Dr. Samuel Thevasagayam, Deputy Director of Agricultural Development at the Bill and Melinda Gates Foundation said:
“Approximately 60 per cent of smallholder farmers depend on livestock for their wellbeing in Africa and South Asia. It is estimated that 25 per cent of livestock production is lost due to preventable or treatable diseases. One of the major reasons attributable for the lack of availability and accessibility of quality veterinary medicines and vaccines is the lack of an appropriate, robust and functioning regulatory system.

“We are working, with our partners in the animal health industry and regulatory agencies, to establish a robust regulatory framework that is effective, transparent and predictable to address this massive need to eliminate the leakage of value from livestock production and help small holder farmers realise the value of livestock by further investing in feed, livestock genetics and improved husbandry.”

Closing the conference, HealthforAnimals’ executive director, Carel du Marchie Sarvaas said: “The purpose of the conference was to bring together people from a range of sectors to help build a greater bond, and in turn, better animal health. A key theme of the day has been harmonisation. Chiefly the need for regulators and governments to collaborate together with other stakeholders.

“Access to quality veterinary medicines not only protect animals but humans, their livelihoods and wellbeing. We hope all those at the conference apply and share today’s learnings to help us all make animals healthier.”
 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.